Royalty Pharma (RPRX) came out with quarterly earnings of $1.17 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.04 per share a year ago.

Anika Therapeutics (ANIK) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.25 per share a year ago.

Vishay Intertechnology (VSH) came out with quarterly earnings of $0.04 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.08 per share a year ago.

Sleep Number (SNBR) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to a loss of $0.14 per share a year ago.

Fiverr International (NYSE: FVRR) reported Q3 2025 results on Nov.

For the first time in months, contrarians are giving gold GC00+0.72% the benefit of the doubt. The source of this big shift was market timers' response to gold's “flash crash” in late October.

COLORADO SPRINGS, Colo. , Nov. 5, 2025 /PRNewswire/ -- Century Casinos, Inc. (Nasdaq Capital Market®: CNTY) announced today that the Company will release its earnings for the third quarter 2025 on Monday, November 10, 2025.

DigitalOcean (NYSE: DOCN) reported Q3 2025 earnings on Oct.

Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines". LOS ANGELES , Nov. 5, 2025 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific breakthrough: its next-generation immune cell therapy led to complete regression of both primary and metastatic pancreatic tumors in humanized mouse models.

Bank of America Corp. lifted its outlook for long-term profit growth on Wednesday, but investors weren't impressed enough to push the megabank's stock — which has seen stellar gains so far this year — up further.

Sachem Capital Corp. (SACH) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.01. This compares to a loss of $0.13 per share a year ago.

Viridian Therapeutics, Inc. (VRDN) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.82. This compares to a loss of $1.15 per share a year ago.

Arvinas, Inc. (ARVN) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.75. This compares to a loss of $0.68 per share a year ago.

Novo Nordisk CEO Mike Doustdar joins 'Squawk Box' to discuss the company's quarterly earnings results, the company's bid for obesity biotech company Metsera, negotiations with the Trump administration to sell some of its obesity drugs to consumers at a lower rate, expanding the use of obesity drug, and more.

Rivian Automotive Inc. (NASDAQ: RIVN) posted another quarter that shows how little progress it has made in the electric vehicle (EV) sector.

Unity Software (NYSE: U) delivered a blowout third quarter on Wednesday morning, crushing both revenue and earnings expectations in a dramatic turnaround from the company's disastrous Q1 performance earlier this year.

Innovative solutions address installation efficiency and privacy options for modern outdoor spaces CHICAGO , Nov. 5, 2025 /PRNewswire/ -- TimberTech®, a brand that's part of the James Hardie portfolio and the leading manufacturer of premium composite and PVC decking and railing solutions, announced the launch of two new innovative products designed to enhance outdoor living spaces: Advantage Rail™ and Impression Privacy Screen™. In addition, Fulton Rail® from the TimberTech metal railing lineup is now available for shipment nationwide.

PLANO, Texas--(BUSINESS WIRE)---- $TYL #TylerTech--Tyler Technologies will participate in five investor conferences in November and December 2025.

VSAT's Q2 results hinge on defense gains, new tech launches and broadband breakthroughs to offset communication softness.

Avanos Medical (AVNS) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.36 per share a year ago.